Malate dehydrogenase 2 confers docetaxel resistance via regulations of JNK signaling and oxidative metabolism.
about
Proteomic Analysis of Anticancer TCMs Targeted at MitochondriaA Novel Malate Dehydrogenase 2 Inhibitor Suppresses Hypoxia-Inducible Factor-1 by Regulating Mitochondrial RespirationInfluenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance.Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancerEnriched environment inhibits mouse pancreatic cancer growth and down-regulates the expression of mitochondria-related genes in cancer cells.Functional regulation of hypoxia inducible factor-1α by SET9 lysine methyltransferase.Amino Acid Profiling of Zinc Resistant Prostate Cancer Cell Lines: Associations With Cancer Progression.Visnagin-a new protectant against doxorubicin cardiotoxicity? Inhibition of mitochondrial malate dehydrogenase 2 (MDH2) and beyond.Identification of malate dehydrogenase 2 as a target protein of the HIF-1 inhibitor LW6 using chemical probes.Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cellsAsparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAP1 modulating the EGFR/JNK/ERK signaling pathway.Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia.Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression.
P2860
Q26777099-B1D73166-B7D5-4865-A722-B272CB7DC70DQ28553959-61C4B88C-D7F0-45C9-AABA-318AACD92097Q33551458-A2181EF4-14C3-4091-B971-EF1BB2A2B897Q34460758-DEED240F-5D2C-4E91-A61B-41BE314FAB9DQ34980981-857E9811-3E30-45C3-A67F-0F24AB83B9ABQ35235860-3562AF75-23E0-4BB3-A6B3-F3F3D4008F10Q38720605-5D77D574-C129-4311-B8E8-9961E911B2F5Q38800300-48B1329E-4ECA-4E9F-B621-F9FD5FEF418AQ39112095-7BE692E5-94EC-4CE4-A745-D84696457176Q42250126-E83C3BEA-04B9-44AE-B5BC-342D40014F2EQ42322000-A722F946-97A9-410B-B052-056760D2CC9BQ46988503-18C6FDDB-A0A3-4494-A4EC-6B52C5B79EDFQ55082840-D0A0D27F-748E-4034-A846-3A8BD58B0FA8
P2860
Malate dehydrogenase 2 confers docetaxel resistance via regulations of JNK signaling and oxidative metabolism.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Malate dehydrogenase 2 confers ...... ling and oxidative metabolism.
@en
Malate dehydrogenase 2 confers ...... ling and oxidative metabolism.
@nl
type
label
Malate dehydrogenase 2 confers ...... ling and oxidative metabolism.
@en
Malate dehydrogenase 2 confers ...... ling and oxidative metabolism.
@nl
prefLabel
Malate dehydrogenase 2 confers ...... ling and oxidative metabolism.
@en
Malate dehydrogenase 2 confers ...... ling and oxidative metabolism.
@nl
P2093
P2860
P356
P1433
P1476
Malate dehydrogenase 2 confers ...... aling and oxidative metabolism
@en
P2093
Changhui Xue
Chris T Harvey
David Z Qian
Tomasz M Beer
Vivian Chen
P2860
P304
P356
10.1002/PROS.22650
P50
P577
2013-02-06T00:00:00Z